Therefore, these validated genes are potential key hub genes and critical regulatory factors in BRCA1/2-MUT BC, which could represent new prognostic or diagnostic biomarkers and provide novel insights into the mechanisms of BRCA1/2 mutations in cancer development. The gene discussed is BRCA1; the disease is cancer.